March 13, 2018 / 8:06 PM / 6 months ago

BRIEF-Supernus Announces Proposed Private Offering Of $350 Million Of Convertible Senior Notes

March 13 (Reuters) - Supernus Pharmaceuticals Inc:

* SUPERNUS ANNOUNCES PROPOSED PRIVATE OFFERING OF $350 MILLION OF CONVERTIBLE SENIOR NOTES

* SUPERNUS PHARMACEUTICALS INC - ‍INTENDS TO OFFER $350 MILLION AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE SENIOR NOTES DUE 2023​

* SUPERNUS PHARMACEUTICALS INC - ‍NOTES WILL MATURE ON APRIL 1, 2023, UNLESS EARLIER REPURCHASED OR CONVERTED​

* SUPERNUS PHARMACEUTICALS- TO USE PROCEEDS FROM SALE OF NOTES TO ACQUIRE OR INVEST IN COMPLEMENTARY BUSINESSES, COMPANIES, PRODUCTS AND TECHNOLOGIES​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below